Summary

Persistence Market Research has recently released a comprehensive report on the global animal drug compounding market. The report provides an in-depth analysis of the market dynamics, highlighting key drivers, trends, opportunities, and challenges shaping its growth trajectory. It presents exclusive data and statistics projecting the market's anticipated evolution from 2024 to 2033.

Key Insights:

• Animal Drug Compounding Market Size (2024E): USD 1.4 Billion
• Projected Market Value (2033F): USD 2.4 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 6.2%

Animal Drug Compounding Market - Report Scope:

Animal drug compounding plays a pivotal role in veterinary medicine, offering customized medications tailored to individual animal needs. This market serves veterinary hospitals, clinics, and individual pet owners, addressing various medical conditions in animals through compounded formulations. Market growth is driven by factors such as the increasing pet population, rising demand for personalized veterinary care, and advancements in pharmaceutical compounding technologies, enhancing treatment efficacy and compliance.

Market Growth Drivers:

The global animal drug compounding market is propelled by several key factors, including the growing prevalence of chronic diseases in pets, which require specialized medications not commercially available. Veterinary compounding enables dosage adjustments, flavor customization, and formulation modifications to meet specific patient requirements, thereby improving treatment outcomes and pet owner satisfaction. Moreover, the expanding scope of veterinary services and the adoption of advanced compounding techniques contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the animal drug compounding market faces challenges related to regulatory compliance, quality control standards, and safety concerns associated with compounded medications. Stringent regulations governing veterinary compounding practices impose compliance burdens on manufacturers and veterinarians, influencing market dynamics and operational practices. Additionally, limited awareness among pet owners about the benefits of compounded medications and concerns about product consistency and safety pose challenges to market penetration.

Market Opportunities:

The animal drug compounding market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving pet healthcare models. The integration of digital health technologies, such as telemedicine and online veterinary consultations, enhances access to compounded medications and improves treatment adherence in veterinary practice. Furthermore, the expansion of veterinary compounding beyond traditional medications to include nutritional supplements, dermatological preparations, and pain management solutions broadens market scope and stimulates innovation.
Strategic partnerships, investment in research and development, and the introduction of user-friendly, regulatory-compliant compounding solutions are crucial for capitalizing on emerging opportunities and sustaining market leadership in the dynamic animal drug compounding landscape.

Key Questions Answered in the Report:

• What factors are driving the growth of the animal drug compounding market globally?
• Which animal species and therapeutic areas are driving adoption of compounded medications in veterinary practice?
• How are technological advancements reshaping the competitive landscape of the animal drug compounding market?
• Who are the key players contributing to the animal drug compounding market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global animal drug compounding market?

Competitive Intelligence and Business Strategy:

Leading players in the global animal drug compounding market focus on innovation, quality assurance, and strategic alliances to gain a competitive edge. These companies invest in research and development to enhance product offerings, ensuring compliance with regulatory standards and addressing veterinary healthcare needs effectively. Collaborations with veterinary associations, pet healthcare providers, and regulatory authorities facilitate market access and promote best practices in animal drug compounding.

Key Companies Profiled:

• Hoye's Pharmacy
• Vertisis Custom Pharmacy
• Smith Caldwell Drug Store
• Sixth Avenue Medical Pharmacy
• Dougherty's Pharmacy
• Triangle Compounding Pharmacy Inc.
• Medisca Inc.
• Wedgewood Pharmacy
• Millers Pharmacy
• Chiron Compounding Pharmacy
• MEDS Canadian Compounding Pharmacy
• Aurora Compounding
• Pace Pharmacy
• Victoria Compounding Pharmacy
• Pratt’s Compounding Pharmacy
• People’s Choice Pharmacy

Key Segments Covered in Animal Drug Compounding Industry Research

Product:
• CNS Agents
• Anti-Infective Agents
• Hormones and Substitutes
• Anti-inflammatory Agents
• Others

Animal:
• Companion AnimaL
• Livestock Animals

Formulation:
• Oral
• Injectable
• Others

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmaps
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Adoption Rate - Key Statistics
4.2. Regulatory Scenario
4.3. Disease Epidemiology
4.4. Product USP Analysis
4.5. PESTEL Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Compounding Pharmacies Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Prevalence of Zoonotic Disease
5.2.2. Growing Awareness of Veterinary Compounded Medications
5.2.3. Rising Demand of Animal Compounded Drugs
5.2.4. Increasing Pet Ownerships
5.2.5. Less Availability of Licensed/Branded Medications
5.2.6. Greater Adoption of Flavor Enhanced Medicines
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Animal
6.1.3. By Formulation
6.1.4. By Region
6.2. 2024 Market Scenario
7. Global Animal Drug Compounding Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
8.3.1. CNS Agents
8.3.2. Anti-Infective Agents
8.3.3. Hormones and Substitutes
8.3.4. Anti-inflammatory Agents
8.3.5. Others
8.4. Market Attractiveness Analysis, by Product
9. Global Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033, By Animal
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, By Animal, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Animal, 2024-2033
9.3.1. Companion Animal
9.3.1.1. Cats
9.3.1.2. Dogs
9.3.1.3. Others
9.3.2. Livestock Animals
9.4. Market Attractiveness Analysis, by Animal
10. Global Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033, By Formulation
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, By Formulation, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Formulation, 2024-2033
10.3.1. Oral
10.3.2. Injectable
10.3.3. Others
10.4. Market Attractiveness Analysis, by Formulation
11. Global Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis, by Region
12. North America Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Animal
12.3.4. By Formulation
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Animal
12.4.4. By Formulation
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Country Level Analysis & Forecast
12.7.1. U.S. Animal Drug Compounding Market Analysis
12.7.1.1. Introduction
12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
12.7.1.2.1. By Product
12.7.1.2.2. By Animal
12.7.1.2.3. By Formulation
12.7.2. Canada Animal Drug Compounding Market Analysis
12.7.2.1. Introduction
12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
12.7.2.2.1. By Product
12.7.2.2.2. By Animal
12.7.2.2.3. By Formulation
13. Latin America Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Animal
13.3.4. By Formulation
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Animal
13.4.4. By Formulation
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. Mexico Animal Drug Compounding Market Analysis
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
13.7.1.2.1. By Product
13.7.1.2.2. By Animal
13.7.1.2.3. By Formulation
13.7.2. Brazil Animal Drug Compounding Market Analysis
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
13.7.2.2.1. By Product
13.7.2.2.2. By Animal
13.7.2.2.3. By Formulation
13.7.3. Argentina Animal Drug Compounding Market Analysis
13.7.3.1. Introduction
13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
13.7.3.2.1. By Product
13.7.3.2.2. By Animal
13.7.3.2.3. By Formulation
14. Europe Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Animal
14.3.4. By Formulation
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Animal
14.4.4. By Formulation
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. Germany Animal Drug Compounding Market Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By Animal
14.7.1.2.3. By Formulation
14.7.2. Italy Animal Drug Compounding Market Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By Animal
14.7.2.2.3. By Formulation
14.7.3. France Animal Drug Compounding Market Analysis
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
14.7.3.2.1. By Product
14.7.3.2.2. By Animal
14.7.3.2.3. By Formulation
14.7.4. U.K. Animal Drug Compounding Market Analysis
14.7.4.1. Introduction
14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
14.7.4.2.1. By Product
14.7.4.2.2. By Animal
14.7.4.2.3. By Formulation
14.7.5. Spain Animal Drug Compounding Market Analysis
14.7.5.1. Introduction
14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
14.7.5.2.1. By Product
14.7.5.2.2. By Animal
14.7.5.2.3. By Formulation
14.7.6. BENELUX Animal Drug Compounding Market Analysis
14.7.6.1. Introduction
14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
14.7.6.2.1. By Product
14.7.6.2.2. By Animal
14.7.6.2.3. By Formulation
14.7.7. Russia Animal Drug Compounding Market Analysis
14.7.7.1. Introduction
14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
14.7.7.2.1. By Product
14.7.7.2.2. By Animal
14.7.7.2.3. By Formulation
15. East Asia Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Formulation (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Animal
15.3.4. By Formulation
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Animal
15.4.3. By Formulation
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. China Animal Drug Compounding Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By Animal
15.7.1.2.3. By Formulation
15.7.2. Japan Animal Drug Compounding Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By Animal
15.7.2.2.3. By Formulation
15.7.3. South Korea Animal Drug Compounding Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. By Animal
15.7.3.2.3. By Formulation
16. South Asia Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Animal
16.3.4. By Formulation
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Animal
16.4.4. By Formulation
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. India Animal Drug Compounding Market Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By Animal
16.7.1.2.3. By Formulation
16.7.2. Indonesia Animal Drug Compounding Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By Animal
16.7.2.2.3. By Formulation
16.7.3. Malaysia Animal Drug Compounding Market Analysis
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
16.7.3.2.1. By Product
16.7.3.2.2. By Animal
16.7.3.2.3. By Formulation
16.7.4. Thailand Animal Drug Compounding Market Analysis
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
16.7.4.2.1. By Product
16.7.4.2.2. By Animal
16.7.4.2.3. By Formulation
17. Oceania Animal Drug Compounding Market 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Animal
17.3.4. By Formulation
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Animal
17.4.4. By Formulation
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Animal Drug Compounding Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By Animal
17.7.1.2.3. By Formulation
17.7.2. New Zealand Animal Drug Compounding Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By Animal
17.7.2.2.3. By Formulation
18. Middle East and Africa (MEA) Animal Drug Compounding Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Animal
18.3.4. By Formulation
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Animal
18.4.3. By Formulation
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. GCC Countries Animal Drug Compounding Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
18.7.1.2.1. By Product
18.7.1.2.2. By Animal
18.7.1.2.3. By Formulation
18.7.2. Turkey Animal Drug Compounding Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
18.7.2.2.1. By Product
18.7.2.2.2. By Animal
18.7.2.2.3. By Formulation
18.7.3. South Africa Animal Drug Compounding Market Analysis
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
18.7.3.2.1. By Product
18.7.3.2.2. By Animal
18.7.3.2.3. By Formulation
18.7.4. North Africa Animal Drug Compounding Market Analysis
18.7.4.1. Introduction
18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
18.7.4.2.1. By Product
18.7.4.2.2. By Animal
18.7.4.2.3. By Formulation
19. Market Structure Analysis
19.1. Market Analysis, by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Medisca Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategy Overview
20.3.1.6.1. Marketing Strategy
20.3.1.6.2. Product Strategy
20.3.1.6.3. Channel Strategy
20.3.2. Hoye's Pharmacy
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategy Overview
20.3.2.6.1. Marketing Strategy
20.3.2.6.2. Product Strategy
20.3.2.6.3. Channel Strategy
20.3.3. Vertisis Custom Pharmacy
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategy Overview
20.3.3.6.1. Marketing Strategy
20.3.3.6.2. Product Strategy
20.3.3.6.3. Channel Strategy
20.3.4. Smith Caldwell Drug Store
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategy Overview
20.3.4.6.1. Marketing Strategy
20.3.4.6.2. Product Strategy
20.3.4.6.3. Channel Strategy
20.3.5. Sixth Avenue Medical Pharmacy
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategy Overview
20.3.5.6.1. Marketing Strategy
20.3.5.6.2. Product Strategy
20.3.5.6.3. Channel Strategy
20.3.6. Dougherty's Pharmacy
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategy Overview
20.3.6.6.1. Marketing Strategy
20.3.6.6.2. Product Strategy
20.3.6.6.3. Channel Strategy
20.3.7. Triangle Compounding Pharmacy Inc.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategy Overview
20.3.7.6.1. Marketing Strategy
20.3.7.6.2. Product Strategy
20.3.7.6.3. Channel Strategy
20.3.8. Medisca Inc.
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategy Overview
20.3.8.6.1. Marketing Strategy
20.3.8.6.2. Product Strategy
20.3.8.6.3. Channel Strategy
20.3.9. Wedgewood Pharmacy
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Key Financials
20.3.9.5. SWOT Analysis
20.3.9.6. Strategy Overview
20.3.9.6.1. Marketing Strategy
20.3.9.6.2. Product Strategy
20.3.9.6.3. Channel Strategy
20.3.10. Millers Pharmacy
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Key Financials
20.3.10.5. SWOT Analysis
20.3.10.6. Strategy Overview
20.3.10.6.1. Marketing Strategy
20.3.10.6.2. Product Strategy
20.3.10.6.3. Channel Strategy
20.3.11. Chiron Compounding Pharmacy
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Key Financials
20.3.11.5. SWOT Analysis
20.3.11.6. Strategy Overview
20.3.11.6.1. Marketing Strategy
20.3.11.6.2. Product Strategy
20.3.11.6.3. Channel Strategy
20.3.12. MEDS Canadian Compounding Pharmacy
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Key Financials
20.3.12.5. SWOT Analysis
20.3.12.6. Strategy Overview
20.3.12.6.1. Marketing Strategy
20.3.12.6.2. Product Strategy
20.3.12.6.3. Channel Strategy
20.3.13. Aurora Compounding
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Sales Footprint
20.3.13.4. Key Financials
20.3.13.5. SWOT Analysis
20.3.13.6. Strategy Overview
20.3.13.6.1. Marketing Strategy
20.3.13.6.2. Product Strategy
20.3.13.6.3. Channel Strategy
20.3.14. Pace Pharmacy
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Sales Footprint
20.3.14.4. Key Financials
20.3.14.5. SWOT Analysis
20.3.14.6. Strategy Overview
20.3.14.6.1. Marketing Strategy
20.3.14.6.2. Product Strategy
20.3.14.6.3. Channel Strategy
20.3.15. Victoria Compounding Pharmacy
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Sales Footprint
20.3.15.4. Key Financials
20.3.15.5. SWOT Analysis
20.3.15.6. Strategy Overview
20.3.15.6.1. Marketing Strategy
20.3.15.6.2. Product Strategy
20.3.15.6.3. Channel Strategy
20.3.16. Pratt’s Compounding Pharmacy
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Sales Footprint
20.3.16.4. Key Financials
20.3.16.5. SWOT Analysis
20.3.16.6. Strategy Overview
20.3.16.6.1. Marketing Strategy
20.3.16.6.2. Product Strategy
20.3.16.6.3. Channel Strategy
20.3.17. People’s Choice Pharmacy
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Sales Footprint
20.3.17.4. Key Financials
20.3.17.5. SWOT Analysis
20.3.17.6. Strategy Overview
20.3.17.6.1. Marketing Strategy
20.3.17.6.2. Product Strategy
20.3.17.6.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology